A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease

Makoto Naganuma, Reiko Kunisaki, Naoki Yoshimura, Yoshiaki Takeuchi, Mamoru Watanabe

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background: Immunosuppressants lead to an increased risk of infection, but few prospective studies have assessed the incidence of opportunistic infections in inflammatory bowel disease (IBD) patients, a high proportion of whom are treated with immunosuppressants. The aim of this study was to assess the age distribution of Japanese IBD patients with opportunistic infections and the risk factors associated with these infections. Methods: A multicenter, prospective study of 570 IBD patients was conducted. The patients were followed for up to 12 months to identify any new infections. The incidence of opportunistic infections and the age distribution of patients with these infections were analyzed. We carried out a case-control study in which 2 non-infected IBD patients were selected as controls for each case (infected IBD patient); the effect of medications on the infection rate was also examined. Results: Fifty-two (9.1 %) of 570 IBD patients developed opportunistic infections. Herpes simplex virus and herpes zoster virus infections were observed in 29 and 16 patients, respectively. No cases of active tuberculosis were observed. The incidence of opportunistic infections in patients aged 50 years or over was significantly higher than that in the other age groups (p = 0.01). The use of steroids (p = 0.02), thiopurine (p < 0.01), and immunosuppressant combination therapy (p < 0.01) was associated with an increased rate of opportunistic infections. However, the use of infliximab was not associated with an increased rate of opportunistic infections (p = 0.62). Multivariate analysis indicated that the use of thiopurine was an independent risk factor for opportunistic infections (p < 0.01). Conclusions: Age ≥50 years and the use of immunosuppressants are risk factors for opportunistic infections in patients with IBD. In our cohort, tuberculosis was not seen as a complication of immunosuppressant therapy.

Original languageEnglish
Pages (from-to)595-600
Number of pages6
JournalJournal of Gastroenterology
Volume48
Issue number5
DOIs
Publication statusPublished - 2013 May

Fingerprint

Opportunistic Infections
Inflammatory Bowel Diseases
Incidence
Immunosuppressive Agents
Infection
Age Distribution
Tuberculosis
Prospective Studies
Human Herpesvirus 3
Virus Diseases
Simplexvirus
Multicenter Studies
Case-Control Studies
Multivariate Analysis
Age Groups
Steroids

Keywords

  • Immunosuppressants
  • Inflammatory bowel disease
  • Opportunistic infection
  • Steroids

ASJC Scopus subject areas

  • Gastroenterology

Cite this

A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease. / Naganuma, Makoto; Kunisaki, Reiko; Yoshimura, Naoki; Takeuchi, Yoshiaki; Watanabe, Mamoru.

In: Journal of Gastroenterology, Vol. 48, No. 5, 05.2013, p. 595-600.

Research output: Contribution to journalArticle

Naganuma, Makoto ; Kunisaki, Reiko ; Yoshimura, Naoki ; Takeuchi, Yoshiaki ; Watanabe, Mamoru. / A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease. In: Journal of Gastroenterology. 2013 ; Vol. 48, No. 5. pp. 595-600.
@article{effe06132a3e486b96345536ffbc15f6,
title = "A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease",
abstract = "Background: Immunosuppressants lead to an increased risk of infection, but few prospective studies have assessed the incidence of opportunistic infections in inflammatory bowel disease (IBD) patients, a high proportion of whom are treated with immunosuppressants. The aim of this study was to assess the age distribution of Japanese IBD patients with opportunistic infections and the risk factors associated with these infections. Methods: A multicenter, prospective study of 570 IBD patients was conducted. The patients were followed for up to 12 months to identify any new infections. The incidence of opportunistic infections and the age distribution of patients with these infections were analyzed. We carried out a case-control study in which 2 non-infected IBD patients were selected as controls for each case (infected IBD patient); the effect of medications on the infection rate was also examined. Results: Fifty-two (9.1 {\%}) of 570 IBD patients developed opportunistic infections. Herpes simplex virus and herpes zoster virus infections were observed in 29 and 16 patients, respectively. No cases of active tuberculosis were observed. The incidence of opportunistic infections in patients aged 50 years or over was significantly higher than that in the other age groups (p = 0.01). The use of steroids (p = 0.02), thiopurine (p < 0.01), and immunosuppressant combination therapy (p < 0.01) was associated with an increased rate of opportunistic infections. However, the use of infliximab was not associated with an increased rate of opportunistic infections (p = 0.62). Multivariate analysis indicated that the use of thiopurine was an independent risk factor for opportunistic infections (p < 0.01). Conclusions: Age ≥50 years and the use of immunosuppressants are risk factors for opportunistic infections in patients with IBD. In our cohort, tuberculosis was not seen as a complication of immunosuppressant therapy.",
keywords = "Immunosuppressants, Inflammatory bowel disease, Opportunistic infection, Steroids",
author = "Makoto Naganuma and Reiko Kunisaki and Naoki Yoshimura and Yoshiaki Takeuchi and Mamoru Watanabe",
year = "2013",
month = "5",
doi = "10.1007/s00535-012-0686-9",
language = "English",
volume = "48",
pages = "595--600",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease

AU - Naganuma, Makoto

AU - Kunisaki, Reiko

AU - Yoshimura, Naoki

AU - Takeuchi, Yoshiaki

AU - Watanabe, Mamoru

PY - 2013/5

Y1 - 2013/5

N2 - Background: Immunosuppressants lead to an increased risk of infection, but few prospective studies have assessed the incidence of opportunistic infections in inflammatory bowel disease (IBD) patients, a high proportion of whom are treated with immunosuppressants. The aim of this study was to assess the age distribution of Japanese IBD patients with opportunistic infections and the risk factors associated with these infections. Methods: A multicenter, prospective study of 570 IBD patients was conducted. The patients were followed for up to 12 months to identify any new infections. The incidence of opportunistic infections and the age distribution of patients with these infections were analyzed. We carried out a case-control study in which 2 non-infected IBD patients were selected as controls for each case (infected IBD patient); the effect of medications on the infection rate was also examined. Results: Fifty-two (9.1 %) of 570 IBD patients developed opportunistic infections. Herpes simplex virus and herpes zoster virus infections were observed in 29 and 16 patients, respectively. No cases of active tuberculosis were observed. The incidence of opportunistic infections in patients aged 50 years or over was significantly higher than that in the other age groups (p = 0.01). The use of steroids (p = 0.02), thiopurine (p < 0.01), and immunosuppressant combination therapy (p < 0.01) was associated with an increased rate of opportunistic infections. However, the use of infliximab was not associated with an increased rate of opportunistic infections (p = 0.62). Multivariate analysis indicated that the use of thiopurine was an independent risk factor for opportunistic infections (p < 0.01). Conclusions: Age ≥50 years and the use of immunosuppressants are risk factors for opportunistic infections in patients with IBD. In our cohort, tuberculosis was not seen as a complication of immunosuppressant therapy.

AB - Background: Immunosuppressants lead to an increased risk of infection, but few prospective studies have assessed the incidence of opportunistic infections in inflammatory bowel disease (IBD) patients, a high proportion of whom are treated with immunosuppressants. The aim of this study was to assess the age distribution of Japanese IBD patients with opportunistic infections and the risk factors associated with these infections. Methods: A multicenter, prospective study of 570 IBD patients was conducted. The patients were followed for up to 12 months to identify any new infections. The incidence of opportunistic infections and the age distribution of patients with these infections were analyzed. We carried out a case-control study in which 2 non-infected IBD patients were selected as controls for each case (infected IBD patient); the effect of medications on the infection rate was also examined. Results: Fifty-two (9.1 %) of 570 IBD patients developed opportunistic infections. Herpes simplex virus and herpes zoster virus infections were observed in 29 and 16 patients, respectively. No cases of active tuberculosis were observed. The incidence of opportunistic infections in patients aged 50 years or over was significantly higher than that in the other age groups (p = 0.01). The use of steroids (p = 0.02), thiopurine (p < 0.01), and immunosuppressant combination therapy (p < 0.01) was associated with an increased rate of opportunistic infections. However, the use of infliximab was not associated with an increased rate of opportunistic infections (p = 0.62). Multivariate analysis indicated that the use of thiopurine was an independent risk factor for opportunistic infections (p < 0.01). Conclusions: Age ≥50 years and the use of immunosuppressants are risk factors for opportunistic infections in patients with IBD. In our cohort, tuberculosis was not seen as a complication of immunosuppressant therapy.

KW - Immunosuppressants

KW - Inflammatory bowel disease

KW - Opportunistic infection

KW - Steroids

UR - http://www.scopus.com/inward/record.url?scp=84878109302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878109302&partnerID=8YFLogxK

U2 - 10.1007/s00535-012-0686-9

DO - 10.1007/s00535-012-0686-9

M3 - Article

C2 - 23053426

AN - SCOPUS:84878109302

VL - 48

SP - 595

EP - 600

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - 5

ER -